ATCC scientists and product specialists recently attended and presented research at the Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting in Boston. The five-day meeting of the best minds in tumor immunology was a masterclass in harnessing the power of the immune system to fight and eradicate cancer. With over 6,000 attendees, nearly 1,500 posters, and 75 vendors, the entire event was electric and laser-focused on making cancer immunotherapy a standard of care for oncology patients globally.